You are here

  • Home
  • Archive
  • Volume 64, Issue 11
  • FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment

Article Text

Article menu
Download PDFPDF
Letters
FDG-PET/CT scan of inflammatory spondylodiscitis lesions in ankylosing spondylitis, and short term evolution during anti-tumour necrosis factor treatment
  1. D Wendling1,
  2. O Blagosklonov2,
  3. G Streit1,
  4. G Lehuédé1,
  5. E Toussirot1,
  6. J-C Cardot2
  1. 1Department of Rheumatology, University Teaching Hospital, Boulevard Fleming, F-25030 Besançon, France
  2. 2Department of Nuclear Medicine, University Teaching Hospital, Boulevard Fleming, F-25030 Besançon, France
  1. Correspondence to:
    Professor D Wendling
    daniel.wendlingufc-chu.univ-fcomte.fr

https://doi.org/10.1136/ard.2005.040345

Statistics from Altmetric.com

    Positron emission tomography/computed tomography (PET/CT scan) represents a new molecular imaging modality using physiological tracers to assess a lesion’s metabolic state. [18F]Fluorodeoxyglucose (FDG) PET appears to be very good for the evaluation of cancer lesions and potentially useful in inflammatory rheumatic disorders, but there is scant information in ankylosing spondylitis (AS).

    We evaluated an FDG-PET/CT scan (4 MBq/kg FDG injection, whole body acquisition using a Siemens Biograph Duo device, volumic fixation values are expressed as standardised uptake values (SUVs)), in patients with AS (revised New York criteria) with magnetic resonance imaging (MRI) documented lumbar aseptic spondylodiscitis (discovertebral biopsy in two patients) requiring anti-tumour necrosis factor (TNF) treatment. A second PET evaluation …

    View Full Text